Different outdoor professions have different risks - a cross-sectional study comparing non-melanoma skin cancer risk among farmers, gardeners and mountain guides

2018 ◽  
Vol 32 (10) ◽  
pp. 1695-1701 ◽  
Author(s):  
A. Zink ◽  
L. Tizek ◽  
M. Schielein ◽  
A. Böhner ◽  
T. Biedermann ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals Quality of Life of Patients with Non-melanoma Skin Cancers and their First-degree Relatives in Shiraz, Southern Iran: A Cross-sectional Study

2020 ◽  
Author(s):  
Nasrin Saki ◽  
Maryam Mashhadi Nezhad ◽  
Hengameh Kasraei ◽  
Maryam Rezaee ◽  
Negin Fazelzadeh Haghighi ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Life Quality ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Non Melanoma Skin Cancer ◽  
Significant Difference ◽  
The Mean ◽  
Melanoma Skin

Abstract Background: Skin cancer is the most common cancer in the world. The aim of this study was to evaluate the quality of life (QoL) of both patients with non-melanoma skin cancer and their relatives.Methods: This is an analytical cross-sectional study on patients with non-melanoma skin cancer and their first-degree relatives referred to dermatology clinic of Faghihi Hospital, Shiraz, Iran, 2018. Accordingly, patients and one of their companions were considered as the study group. Their responses to the questionnaires of Dermatology Life Quality Index and Family Dermatology Life Quality Index were analyzed using SPSS software, version 18. Results: The QoL of the patients enrolled in this study was relatively good. The mean of the QoL score for patients with non-melanoma skin cancer was 10.5 ± 6.2 for men and 13.2 ± 7.2 for women which showed a statistically significant difference (P = 0.027). In the patient's companion group, the mean of their QoL scores were 9.4 ± 5.6 in men and 10.9 ± 6.0 in women with no statistically significant difference (P = 0.149).In addition, the QoL in both groups were not related to the type of skin cancer, sex and family relations. Conclusion: The results of this study showed that the overall QoL of the patients and their relatives was moderate. However, a plan for improving QoLs of both groups should be considered as a part of the illness management.

scholarly journals Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study

2019 ◽  
Vol 121 (11) ◽  
pp. 973-978 ◽  
Author(s):  
Anton Pottegård ◽  
Sidsel Arnspang Pedersen ◽  
Sigrun Alba Johannesdottir Schmidt ◽  
Chaw-Ning Lee ◽  
Chao-Kai Hsu ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Asian Population ◽  
Case Control ◽  
Sensitivity Analyses ◽  
Research Database ◽  
Lip Cancer ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Abstract Background The antihypertensive agent hydrochlorothiazide has been associated with increased risks of non-melanoma skin cancer (NMSC) and possibly some melanoma subtypes. Previous studies were, however, conducted in predominantly Caucasian populations. We therefore examined the association between hydrochlorothiazide and skin cancer risk in an Asian population. Methods By using Taiwan’s National Health Insurance Research Database (NHIRD), we conducted three separate case–control studies of lip cancer, non-lip non-melanoma skin cancer and melanoma. Cases (n = 29,082) with a first-ever skin cancer diagnoses (2008–2015) were matched 1:10 to population controls. We estimated odds ratios (ORs) associating hydrochlorothiazide use with skin cancer risk by using conditional logistic regression. Results Hydrochlorothiazide use showed no overall association with any of the three outcomes: ORs for high cumulative use of HCTZ (≥50,000 mg) were 0.86 (95% CI 0.09–7.81) for lip cancer, 1.16 (95% CI 0.98–1.37) for non-lip NMSC and 1.07 (95% CI 0.65–1.76) for melanoma. There was some evidence of a dose–response pattern for non-lip NMSC, with an OR of 1.66 (95% CI 0.82–3.33) for 100,000–149,999 mg of HCTZ. The null findings were robust across subgroup and sensitivity analyses. Conclusion Use of HCTZ appears safe in terms of skin cancer risk in an Asian population.

Non-melanoma skin cancer risk in the Queensland renal transplant population

2002 ◽  
Vol 147 (5) ◽  
pp. 950-956 ◽  
Author(s):  
H.M. Ramsay ◽  
A.A. Fryer ◽  
C.M. Hawley ◽  
A.G. Smith ◽  
D.L. Nicol ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Renal Transplant ◽  
Cancer Risk ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals P691 UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBD

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S433-S434
Author(s):  
Y. Wu ◽  
S. Ghaly ◽  
S. Kerr ◽  
K. Krishnaprasad ◽  
R. Prosser ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Skin Type ◽  
Uv Exposure ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals Reducing Non‐Melanoma Skin Cancer Risk in Renal Transplant Recipients

Nephrology ◽  
2021 ◽  
Author(s):  
Zaw Thet ◽  
Alfred K. Lam ◽  
Dwarakanathan Ranganathan ◽  
Soe Yu Aung ◽  
Thin Han ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Renal Transplant ◽  
Cancer Risk ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients

2006 ◽  
Vol 15 (12) ◽  
pp. 958-965 ◽  
Author(s):  
Macarena Gomez Lira ◽  
Lisa Provezza ◽  
Giovanni Malerba ◽  
Luigi Naldi ◽  
Giuseppe Remuzzi ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Gene Polymorphisms ◽  
Glutathione S Transferase ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Cyp1a1 Gene ◽  
Melanoma Skin
Sign in / Sign up

Export Citation Format

Share Document